CD47 and neoplasm: These engineered exosomes possess evasion capabilities against phagocytosis, attributed to the abundant CD47 proteins from RBC membranes, alongside specialized tumor-homing properties conferred by cancer cell-derived proteins, including EpCAM, Galectin 3, and N Cadherin [15].